BRISTOL, Tenn., Feb. 28 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company plans to announce earnings for
the fourth quarter and year ending December 31, 2004, prior to the market open
on Tuesday, March 15, 2005.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the fourth quarter and year ending December
31, 2004. These forward-looking statements involve certain significant risks
and uncertainties, and actual results may differ materially from the
forward-looking statements. Some important factors which may cause results to
differ include: dependence on King's ability to release the Company's
financial results for fourth quarter and year ending December 31, 2004 as
currently planned on March 15, 2005. Other important factors that may cause
actual results to differ materially from the forward-looking statements are
discussed in the "Risk Factors" section and other sections of King's Form 10-K
for the year ended December 31, 2003 and Form 10-Q for the second quarter
ended June 30, 2004, which are on file with the Securities and Exchange
Commission. King does not undertake to publicly update or revise any of its
forward-looking statements even if experience or future changes show that the
indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green of King Pharmaceuticals, Inc.,
Executive Vice President, Corporate Affairs, +1-423-989-8125
|
